Does Use of Topical Lidocaine in EGD Reduce Amount of IV Midazolam and Fentanyl Required and Shorten Recovery Time

Status unconfirmed · Not applicable · Has a placebo group

Conditions studied: Dysphagia, GERD, Abdominal Pain

In brief

Patients will be randomized to a placebo or study group who will receive topical lidocaine prior to EGD. Amount of medication used, recovery time, patient/endoscopist satisfaction will then be assessed.

Key facts

Study ID

NCT02620501

Run by

Brooke Army Medical Center

People needed

106

Starts

2015-07-01

Expected to finish

2016-05-01

Last updated by the study team

2015-12-03

Who can join

Age: 18 and older, up to 89. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• EGD alone performed by staff gastroenterologist as an outpatient
• Between the age of 18 and 89
• Not requiring anesthesia support or use of medications other than fentanyl and midazolam

You may not qualify if…

• Prior history of head and neck surgery
• Known hypersensitivity to local anesthetics, the amide type or any components of the topical lidocaine
• Patients having interventions other than polypectomy performed
• Pregnant or breast feeding females
• Patients with severe liver impairment
• Known hypersensitivity to benzodiazepine or fentanyl

Where it is running

• Brooke Army Medical Center — Fort Sam Houston, Texas, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.